CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

Inger S. Nijhof; Tineke Casneuf; Jeroen van Velzen; Berris van Kessel; Amy E. Axel; Khaja Syed; Richard W. J. Groen; Mark van Duin; Pieter Sonneveld; Monique C. Minnema; Sonja Zweegman; Christopher Chiu; Andries C. Bloem; Tuna Mutis; Henk M. Lokhorst; A. Kate Sasser; Niels W. C. J. van de Donk

doi:https://doi.org/10.1182/blood-2016-03-703439

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

Inger S. Nijhof, Tineke Casneuf, Jeroen van Velzen, Berris van Kessel, Amy E. Axel, Khaja Syed, Richard W. J. Groen, Mark van Duin, Pieter Sonneveld, Monique C. Minnema, Sonja Zweegman, Christopher Chiu, Andries C. Bloem, Tuna Mutis, Henk M. Lokhorst, A. Kate Sasser, Niels W. C. J. van de Donk

Research output: Contribution to journal › Article › Academic › peer-review

264 Citations (Scopus)

Original language	English
Pages (from-to)	959-970
Journal	Blood
Volume	128
Issue number	7
DOIs	https://doi.org/10.1182/blood-2016-03-703439
Publication status	Published - 18 Aug 2016

Access to Document

https://doi.org/10.1182/blood-2016-03-703439

Cite this

Nijhof, I. S., Casneuf, T., van Velzen, J., van Kessel, B., Axel, A. E., Syed, K., Groen, R. W. J., van Duin, M., Sonneveld, P., Minnema, M. C., Zweegman, S., Chiu, C., Bloem, A. C., Mutis, T., Lokhorst, H. M., Sasser, A. K., & van de Donk, N. W. C. J. (2016). CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. Blood, 128(7), 959-970. https://doi.org/10.1182/blood-2016-03-703439

@article{186090a033ae4ab39d9800aad9c94504,

title = "CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma",

author = "Nijhof, {Inger S.} and Tineke Casneuf and {van Velzen}, Jeroen and {van Kessel}, Berris and Axel, {Amy E.} and Khaja Syed and Groen, {Richard W. J.} and {van Duin}, Mark and Pieter Sonneveld and Minnema, {Monique C.} and Sonja Zweegman and Christopher Chiu and Bloem, {Andries C.} and Tuna Mutis and Lokhorst, {Henk M.} and Sasser, {A. Kate} and {van de Donk}, {Niels W. C. J.}",

year = "2016",

month = aug,

day = "18",

doi = "https://doi.org/10.1182/blood-2016-03-703439",

language = "English",

volume = "128",

pages = "959--970",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "7",

}

Nijhof, IS, Casneuf, T, van Velzen, J, van Kessel, B, Axel, AE, Syed, K, Groen, RWJ, van Duin, M, Sonneveld, P, Minnema, MC, Zweegman, S, Chiu, C, Bloem, AC, Mutis, T, Lokhorst, HM, Sasser, AK & van de Donk, NWCJ 2016, 'CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma', Blood, vol. 128, no. 7, pp. 959-970. https://doi.org/10.1182/blood-2016-03-703439

TY - JOUR

T1 - CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

AU - Nijhof, Inger S.

AU - Casneuf, Tineke

AU - van Velzen, Jeroen

AU - van Kessel, Berris

AU - Axel, Amy E.

AU - Syed, Khaja

AU - Groen, Richard W. J.

AU - van Duin, Mark

AU - Sonneveld, Pieter

AU - Minnema, Monique C.

AU - Zweegman, Sonja

AU - Chiu, Christopher

AU - Bloem, Andries C.

AU - Mutis, Tuna

AU - Lokhorst, Henk M.

AU - Sasser, A. Kate

AU - van de Donk, Niels W. C. J.

PY - 2016/8/18

Y1 - 2016/8/18

U2 - https://doi.org/10.1182/blood-2016-03-703439

DO - https://doi.org/10.1182/blood-2016-03-703439

M3 - Article

C2 - 27307294

SN - 0006-4971

VL - 128

SP - 959

EP - 970

JO - Blood

JF - Blood

IS - 7

ER -